Crystec to present at Inhalation Asia 2019, 13-15 November, Hong Kong
Inhalation Asia is a non-commercial conference that aims to provide an opportunity for people who work on pulmonary and intranasal drug delivery in Asia to network and showcase their research, products and services. The event will take place at the Hong Kong Science and Technology Park in Sha Tin.
Crystec’s Chief Operations Officer, Qun Shao, will take the stage in on Wednesday 13th November as part of a session looking at the application of inhaled therapies beyond the treatment of lung disease. Here he will present ‘An Inhaled Therapy for Urge Urinary Incontinence (UUI)’, a novel formulation of an existing therapy, and the first on-demand therapy for the treatment of UUI, representing a potentially transformative change in the modality of treating this episodic condition.
For more information about the event, please visit https://www.inhalationasia.org/.
To book a meeting in Hong Kong, or to learn more about Crystec, our capabilities and our products, please get in touch with Wenwen Zhao (firstname.lastname@example.org).